Sandoz Group AG (SDZNY) reports robust financial growth with a 5% increase in net sales and strategic advancements in biosimilars, despite challenges in the penicillin market.
Replacing the world's wonder drug with something bacteria can't resist Antibiotic resistant bacteria are spreading, and the ...
Maintaining good oral health helps to prevent dental infections. If you develop pain or swelling in your mouth, call a ...
Investing.com -- Sandoz Group AG (SIX: SDZ) on Wednesday reported full-year 2025 results that met analyst expectations and issued fiscal 2026 guidance slightly above consensus, signaling confidence in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results